Sreenath M Krishnan

5PUBLICATIONS
29CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 11, 2023
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Han Liu, Ana-Marija Milenković-Grišić, Sreenath M Krishnan

|Jan 06, 2023
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study.

Sreenath M Krishnan, Lena E Friberg, François Mercier

|Oct 04, 2022
Bayesian forecasting of tumor size metrics and overall survival.

Sreenath M Krishnan, Lena E Friberg

|Apr 05, 2021
Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2-negative breast cancer patients treated with docetaxel.

Sreenath M Krishnan, Sofiene S Laarif, Brendan C Bender

Pageof 1